Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
Azenta, Inc. logo

NASDAQ · AZTA

Azenta, Inc.

Healthcare · Medical - Instruments & Supplies

$39.06

Down-$2.21 (-5.35%)

Updated Nov 1, 2026, 8:43 PM

SID Score

6.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.72B
P/E ratio
-28.92
Dividend yield
0.00%
52-week range
$15.93 – $46.41
Volume
902.82K
Avg. volume
606.52K

Price performance · AZTA

AZTA price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

AZTA closed at $39.06 after 20 trading sessions, down 8.59% for the selected period.

Last close
$39.06
Period change
-8.59%
Period low
$34.09
Period high
$42.73
Daily close
View OHLC price history
AZTA OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$39.56$40.36$38.0688$39.06902.82K
Oct 29, 2026$40.61$41.705$40.455$41.27829.51K
Oct 28, 2026$39.06$41.26$39.05$40.63900.74K
Oct 27, 2026$37.14$40.27$36.875$39.081.68M
Oct 26, 2026$36.60$37.325$36.52$37.17657.94K
Oct 23, 2026$35.67$36.595$35.21$36.50478.68K
Oct 22, 2026$36.66$37.23$35.509$36.01813.31K
Oct 21, 2026$35.44$37.10$34.93$36.76635.73K
Oct 20, 2026$35.04$36.41$34.51$35.73769.85K
Oct 19, 2026$34.55$35.56$34.10$34.84791.9K
Oct 16, 2026$36.52$37.368$33.03$34.091.26M
Oct 15, 2026$36.95$37.11$35.195$36.521.22M
Oct 14, 2026$37.48$38.92$37.055$37.181.11M
Oct 13, 2026$37.77$38.395$37.18$37.87663.25K
Oct 12, 2026$37.42$37.99$36.57$37.771.04M
Oct 9, 2026$35.94$38.34$35.875$37.721.16M
Oct 8, 2026$35.74$36.19$34.925$36.001.22M
Oct 7, 2026$38.33$39.105$35.555$35.891.69M
Oct 6, 2026$43.755$46.41$39.33$39.352.54M
Oct 5, 2026$39.49$43.215$38.835$42.732.37M

Latest AZTA news

The latest Smart Investors Daily articles mentioning AZTA.

Stock researchCompany · Overview

AZTA research

Overview

Company profile and research snapshot.

Company profile

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$38.67
Implied upside
—
Analysts
—
AZTA recent ratings
DateFirmRatingTarget
Sep 14, 2026NeedhamBuy—
Aug 6, 2026Evercore ISI GroupOutperform—
Aug 5, 2026NeedhamBuy—
May 6, 2026NeedhamBuy—
Apr 6, 2026Evercore ISI GroupOutperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 18, 2026

Azenta (AZTA) Could Be 14% Below Fair Value Following Margin Expansion Narrative

Recent Trading Context For Azenta Azenta (AZTA) has drawn attention after recent trading left the share price at $34.09, with moves that now reflect a mixed pattern across the past week, month and past 3 months. Recent trading has cooled after a strong run, with Azenta’s share price falling 6.65% over the last day and 9.62% over the past week. However, the 3 month share price return of 29.82% and 1 year total shareholder return of 10.07% still point to momentum that contrasts with weaker 3...

Yahoo · Oct 18, 2026

Azenta (AZTA) Stock Could Be Undervalued Even With Legal Scrutiny

Azenta has had a mixed share price story over the past few years, and recent legal scrutiny around its former CEO has pushed the spotlight back onto the basics. The key issue for Azenta now is whether the current valuation can be squared with what its sales actually support. Over the past 5 years the stock has fallen 68.6%, which raises a direct question about how the current market value lines up with the revenue base of the business. The August 2026 resignation of President and CEO John P...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By